Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

Angela R. Branche, Nadine G. Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer, David J. Diemert, Patricia L. Winokur, Rachel M. Presti, Angelica C. Kottkamp, Ann R. Falsey, Sharon E. Frey, Richard Rupp, Martín Bäcker, Richard M. Novak, Emmanuel B. Walter, Lisa A. Jackson, Susan J. Little, Lilly C. Immergluck, Siham M. Mahgoub, Jennifer A. Whitaker, Tara M. Babu, Paul A. Goepfert, Dahlene N. Fusco, Robert L. Atmar, Christine M. Posavad, Antonia Netzl, Derek J. Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K. Makhene, Sonja Crandon, David C. Montefiori, Paul C. Roberts, John H. Beigel
doi: https://doi.org/10.1101/2023.01.31.23285306

Article Information

doi 
https://doi.org/10.1101/2023.01.31.23285306
History 
  • March 31, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Angela R. Branche1,*,‡,
  2. Nadine G. Rouphael2,*,†,
  3. Cecilia Losada2,
  4. Lindsey R. Baden3,
  5. Evan J. Anderson4,
  6. Anne F. Luetkemeyer5,
  7. David J. Diemert6,
  8. Patricia L. Winokur7,
  9. Rachel M. Presti8,
  10. Angelica C. Kottkamp9,
  11. Ann R. Falsey1,
  12. Sharon E. Frey10,
  13. Richard Rupp11,
  14. Martín Bäcker12,
  15. Richard M. Novak13,
  16. Emmanuel B. Walter14,
  17. Lisa A. Jackson15,
  18. Susan J. Little16,
  19. Lilly C. Immergluck17,
  20. Siham M. Mahgoub18,
  21. Jennifer A. Whitaker19,
  22. Tara M. Babu20,
  23. Paul A. Goepfert21,
  24. Dahlene N. Fusco22,
  25. Robert L. Atmar19,
  26. Christine M. Posavad23,
  27. Antonia Netzl24,
  28. Derek J. Smith24,
  29. Kalyani Telu25,
  30. Jinjian Mu25,
  31. Mat Makowski25,
  32. Mamodikoe K. Makhene26,
  33. Sonja Crandon26,
  34. David C. Montefiori27,
  35. Paul C. Roberts26 and
  36. John H. Beigel26
  1. 1University of Rochester VTEU, Rochester, NY
  2. 2Emory University Hope Clinic, Decatur, GA
  3. 3Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
  4. 4Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA
  5. 5Zuckerberg San Francisco General, University of California San Francisco, San Francisco, CA
  6. 6George Washington Vaccine Research Unit, George Washington University, Washington D.C
  7. 7University of Iowa College of Medicine, Iowa City, IA
  8. 8Washington University School of Medicine, St. Louis, MO
  9. 9NYU VTEU Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
  10. 10Saint Louis University, Center for Vaccine Development, St. Louis, MO
  11. 11University of Texas Medical Branch, Galveston, TX
  12. 12NYU VTEU Long Island Research Clinic at NYU Long Island School of Medicine, Mineola, NY
  13. 13University of Illinois at Chicago-Project WISH, Chicago, IL
  14. 14Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
  15. 15Kaiser Permanente Washington Health Research Institute, Seattle, WA
  16. 16Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA
  17. 17Morehouse School of Medicine, Atlanta, GA
  18. 18Howard University College of Medicine, Howard University Hospital, Washington D.C
  19. 19Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
  20. 20Departments of Medicine, Epidemiology, and Laboratory Medicine & Pathology, University of Washington, Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA
  21. 21University of Alabama at Birmingham, Birmingham, AL
  22. 22Tulane University School of Medicine, New Orleans, LA
  23. 23IDCRC Laboratory Operations Unit – Fred Hutchinson Cancer Center and University of Washington, Seattle, WA
  24. 24Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
  25. 25The Emmes Company, LLC, Rockville, MD
  26. 26Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
  27. 27Duke University, Durham, NC
  1. ↵‡Corresponding Author
    Nadine Rouphael, MD, Professor of Medicine, Emory University, Hope Clinic, Emory Vaccine Center, 500 Irvin Court, Suite 200, Decatur, GA 30030, Tel: 404-712-1435, Fax: 404-499-9727, Email: nroupha{at}emory.edu
  2. ↵†Alternate Corresponding Author
    Angela Branche, MD, Associate Professor of Medicine, University of Rochester, 601 Elmwood Avenue, Box 689, Rochester, NY 14642, Tel: 585-273-4104, Email: angela_branche{at}urmc.rochester.edu
Back to top
Posted March 31, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial
Angela R. Branche, Nadine G. Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer, David J. Diemert, Patricia L. Winokur, Rachel M. Presti, Angelica C. Kottkamp, Ann R. Falsey, Sharon E. Frey, Richard Rupp, Martín Bäcker, Richard M. Novak, Emmanuel B. Walter, Lisa A. Jackson, Susan J. Little, Lilly C. Immergluck, Siham M. Mahgoub, Jennifer A. Whitaker, Tara M. Babu, Paul A. Goepfert, Dahlene N. Fusco, Robert L. Atmar, Christine M. Posavad, Antonia Netzl, Derek J. Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K. Makhene, Sonja Crandon, David C. Montefiori, Paul C. Roberts, John H. Beigel
medRxiv 2023.01.31.23285306; doi: https://doi.org/10.1101/2023.01.31.23285306
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area